Skip to main content

Table 2 Body composition and physical fitness

From: Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial

 

AIT (n = 26)

LED + AIT (n = 29)

Between-group 1 yeara

p

Baseline

Change baseline to 1 year

p

Change 12 weeks to 1 year

p

Baseline

Change baseline to 1 year

p

Change 12 weeks to 1 year

p

Body composition

 Weight (kg)

96.2 (13.8)

− 1.7 (− 0.7; − 2.6)

< 0.001

− 0.4 (− 1.4; 0.6)

0.406

95.6 (10.7)

− 7.2 (− 8.4; − 6.1)

< 0.0 01

2.5 (1.3; 3.6)

< 0.001

5.6 (4.1; 7.1)

< 0.001

 Body mass index (kg/m2)

32.1 (3.2)

− 0.6 (− 0.9; − 0.2)

0.001

− 0.1 (− 0.5; 0.2)

0.408

32.2 (3.1)

− 2.5 (− 2.9; − 2.1)

< 0.001

0.8 (0.4; 1.2)

< 0.001

1.90 (1.37; 2.42)

< 0.001

 Body fat mass (kg)

32.6 (7.6)

− 1.9 (− 2.8; − 1.0)

< 0.001

− 0.3 (− 1.2; 0,5)

0.448

34.6 (8.0)

− 6.6 (− 7.7; − 5.5)

< 0.001

1.9 (0.8; 3.1)

< 0.001

4.7 (3.2; 6.2)

< 0.001

 Body fat %

34.6 (6.5)

− 1.5 (− 2.4; − 0.7)

< 0.001

0.2 (− 1.0; 0.6)

0.618

36.7 (6.8)

− 4.7 (− 5.8; − 3.7)

< 0.001

1.6 (0.5; 2.7)

0.003

3.2 (1.8; 4.6)

< 0.001

 Fat free mass (kg)

62.9 (9.9)

0.2 (− 0.5; 0.9)

0.564

− 0.3 (− 0.9; 0.4)

0.430

60.4 (8.8)

− 0.5 (− 1.1; 0.02)

0.060

0.3 (− 0.2; 0.9)

0.240

0.7 (− 0.1; 1.6)

0.096

 Waist (cm)

109.9 (9.5)

− 3.3 (− 5.1; − 1.5)

< 0.001

− 0.4 (− 2.2; 1.4)

0.696

107.7 (7.1)

− 6.6 (− 8.6; − 4.6)

< 0.001

3.2 (1.2; 5.2)

0.002

3.3 (0.6; 6.1)

0.018

 Hip (cm)

110.8 (8.0)

− 4.0 (− 5.1; − 2.9)

< 0.001

− 1.7 (− 2.8; − 0.6)

0.003

110.3 (7.5)

− 6.0 (− 7.4; − 4.7)

< 0.001

0.9 (− 0.4; 2.2)

0.201

2.0 (0.3; 3.8)

0.025

 Waist/hip– ratio

0.99 (0.1)

0.005 (− 0.01; 0.02)

0.512

0.01 (− 0.003; 0.03)

0.116

0.98 (0.1)

− 0.01 (− 0.03; 0.01)

0.397

0.02 (0.01; 0.02)

0.008

0.01 (− 0.01; 0.04)

0.295

Physical fitness

 VO2peaktotal (mL/min)

1997 (463)

95 (− 30; 221)

0.135

− 123 (− 249; 2)

0.053

1981 (533)

132 (37; 227)

0.007

196 (102; 292)

< 0.001

− 36 (− 192; 119)

0.645

 VO2peakkg (mL/kg/min)

20.8 (4.9)

1.5 (0.2; 2.9)

0.027

− 1.0 (− 2.3; 0.4)

0.150

20.6 (5.2)

3.1 (2.9; 4.2)

< 0.001

1.5 (0.4; 2.7)

0.007

− 1.6 (− 3.3; 0.2)

0.077

 VO2peakffm (mL/kg fat free mass0.67/min)

124.0 (24.3)

5.9 (− 1.9; 13.7)

0.138

− 7.4 (− 15.2; 0.4)

0.065

125.5 (25.2)

8.7 (2.8; 14.6)

0.004

11.9 (6.0; 17.9)

< 0.001

− 2.8 (− 12.4; 6.9)

0.575

 Peak RER

1.19 (0.08)

0.0002 (− 0.03; 0.03)

0.989

0.01 (− 0.02; 0.04)

0.602

1.18 (0.09)

0.06 (− 0.02; 0.09)

< 0.001

0.00001 (− 0.03; 0.03)

0.999

− 0.05 (− 0.1; − 0.01)

0.018

 Max workload (W)

158 (42)

13 (2; 23)

0.017

− 7.6 (− 18; 3)

0.155

155 (48)

15 (9; 22)

< 0.001

15 (9; 22)

< 0.001

− 2.5 (− 14.4; 9.5)

0.687

 Peak heart rate

137 (23)

1 (− 4; 7)

0.638

1 (− 6; 5)

0.826

135 (22)

9 (4; 13)

< 0.001

9 (− 4; 14)

< 0.001

− 7.4 (− 14.5; − 0.3)

0.040

  1. Intention-to-treat analysis. Baseline: mean (SD) Baseline data are presented as mean (SD), within- and between-group differences are presented with 95% CI. AIT, Aerobic interval training, LED, Low energy diet, VO2peaktotal, Total peak aerobic capacity, VO2peakbw, Peak aerobic capacity corrected for body weight, VO2peakffm, Peak aerobic capacity corrected for fat free mass, CPET, Cardiopulmonary exercise test, RER, respiratory exchange ratio
  2. aBetween-group difference at 1 year corrected for baseline difference
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840